CLGN
CollPlant Biotechnologies Ltd Ordinary Shares
Orthopedic, Prosthetic & Surgical Appliances & Supplies
Best Orthopedic Devices Stocks 2026 →
CLGN Stock Analysis: Buy, Sell, or Hold?
$4.64
+0.68 (+17.17%)
▲
5d:
+17.77%
30d:
+12.35%
90d:
+1307.34%
QUANTITATIVE VERDICT
WAIT
LOW Confidence (29%)
Quality Score
41/100
Position
EXTENDED
30-Day Fair Range
$3.60 – $4.19
Position: EXTENDED
Forward P/E & Valuation
-25.8x
CHEAP
vs 3.5x historical avg
Wall Street Target
$11.12
+139.7% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$3.76 / $4.64
Trend: Strong Uptrend
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
⏸️ WAIT FOR BETTER ENTRY: CLGN is 10.7% above its trading range ($4.19). Market expects 0% annual growth, but current price leaves little margin for error. While momentum could continue, risk/reward favors waiting for a pullback.
Get Alerted When CLGN Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
In-depth Analysis How we analyze
Valuation Analysis: CLGN is currently trading at $4.64, which is considered extended relative to its 30-day fair value range of $3.60 to $4.19. From a valuation perspective, the stock is trading at a discount (Forward PE: -25.8) compared to its historical average (3.5). At these levels, the market is pricing in 0% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, CLGN is in a strong uptrend. The price is approaching resistance at $4.64. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 17.2% recently.
Market Sentiment: CLGN scores 33/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $11.12 (+139.7%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, CLGN is in a strong uptrend. The price is approaching resistance at $4.64. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 17.2% recently.
Market Sentiment: CLGN scores 33/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $11.12 (+139.7%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$3.60 -
$4.19
Company Quality Score
41/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
28.6%
Trading Range & Key Levels
30-Day Trading Range
$3.60 -
$4.19
Current vs Trading Range
EXTENDED
Support Level
$3.76
Resistance Level
$4.64
Current Trend
Strong Uptrend
Technical data as of
Nov 12, 2026
Quantitative Signal Breakdown
- BEARISH: Price significantly overextended (+10.7% above its trading range)
- BEARISH: Weak technical setup (33/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+17.2%)
- BULLISH: Trading 139.7% below Wall St target ($11.12)
- BULLISH: Market expects only 0% annual growth - appears undervalued
- WARNING: Composite score 41/100 in the bottom quintile — this cohort historically lags the market
Fundamental Context
Forward P/E (Next Year Est.)
-25.78
Wall Street Target
$11.12
(+139.7%)
Revenue Growth (YoY)
-39.7%
PE vs Historical
-25.8 vs 3.5
CHEAP
Share CLGN Analysis
Share this live CLGN analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (CLGN)
Bullish
3 Retail Mentions
StockTwits Volume
3 msgs
24h retail stream
Last Tracked
Nov 13, 2026
Daily AI digest
AI Retail Discussion Summary:
CollPlant (CLGN) will begin trading on Nasdaq under the new ticker symbol OPHI, reflecting its expansion into photonic computing. The company intends to change its name to OptiPhi Computing Ltd. subject to shareholder approval.
Key Retail Themes:
Company Expansion
Nasdaq Listing
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 13, 2026 5:35 AM ET
Data refreshes hourly during market hours. Next update: 6:35 AM
Data refreshes hourly during market hours. Next update: 6:35 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is CLGN showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
RVMD
Revolution Medicines Inc |
STRONG BUY
25 analysts |
$261 | 38 SELL |
|
VKTX
Viking Therapeutics Inc |
STRONG BUY
21 analysts |
$95 | 41 HOLD |
|
JANX
Janux Therapeutics Inc |
STRONG BUY
18 analysts |
$32 | 42 HOLD |
|
SNDX
Syndax Pharmaceuticals I… |
STRONG BUY
12 analysts |
$35 | 58 HOLD |
|
ACHV
Achieve Life Sciences Inc |
STRONG BUY
12 analysts |
$14 | 56 HOLD |
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive CLGN Research Pages
